ESC Premium Access

How to distinguish between hypertrophic cardiomyopathy and left ventricular hypertrophy secondary to Fabry disease?

Congress Presentation

About the speaker

Doctor Raquel Menezes Fernandes

Algarve University Hospital Center, Faro (Portugal)
2 presentations
0 follower

93 more presentations in this session

Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy

Speaker: Doctor D. Lawin (Bielefeld, DE)

Thumbnail

Cardiac rupture - the most serious complication of takotsubo syndrome

Speaker: Doctor M. Zalewska-Adamiec (Bialystok, PL)

Thumbnail

Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Trongtorsak (Evanston, US)

Thumbnail

Access the full session

Myocardial and pericardial disease e-posters

Speakers: Doctor R. Menezes Fernandes, Professor O. Blagova, Doctor D. Lawin, Doctor M. Zalewska-Adamiec, Professor O. Blagova...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Age-adjusted risk factors are independently associated with an increased risk of ischaemic stroke, transient ischaemic stroke and systemic embolism in the ETNA-AF-Europe registry

27 August 2021

ESC Premium Access

Delays in diagnostic tests used to identify transthyretin amyloid cardiomyopathy (ATTR-CM) in the EU4 + UK

27 August 2021

ESC Premium Access

Exploration of electrocardiographic and echocardiographic findings to screen transthyretin amyloid cardiomyopathy in patients with mild left ventricular hypertrophy

27 August 2021

ESC 365 is supported by

logo Novo Nordisk